SOURCE: Kadmon Corporation

Kadmon Corporation

July 02, 2013 08:00 ET

Kadmon Corporation to Present at the 8th Annual JMP Securities Healthcare Conference

NEW YORK, NY--(Marketwired - Jul 2, 2013) - Kadmon Corporation, LLC, today announced that Samuel D. Waksal, Ph.D., Chairman and Chief Executive Officer of Kadmon, will present at the 8th Annual JMP Securities Healthcare Conference on Tuesday, July 9 at 2:00 p.m. Eastern Time in New York City. Dr. Waksal will provide an overview of Kadmon and its commercial and clinical programs.

A live audio webcast of the presentation will be accessible through Kadmon's website at The webcast will be archived for 90 days.

About Kadmon Corporation

Kadmon Corporation, LLC, is a global company built on a 21st-century paradigm for the translation of innovative science into treatment. The company currently offers products and services for the treatment and management of hepatitis C, and is pioneering novel medicines in areas of serious disease, including oncology, infectious diseases, immunology and neurodegenerative diseases. Emphasizing emerging concepts in molecular biology and genomics, Kadmon is developing treatments and treatment combinations that target the metabolomics and signaling pathways associated with disease, with the goal addressing some of today's most pressing areas of unmet medical need. For more information, visit

Contact Information

  • Contact Information
    David Pitts
    Argot Partners
    Email Contact